全文获取类型
收费全文 | 1341篇 |
免费 | 131篇 |
国内免费 | 148篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 72篇 |
妇产科学 | 10篇 |
基础医学 | 114篇 |
口腔科学 | 30篇 |
临床医学 | 223篇 |
内科学 | 313篇 |
皮肤病学 | 46篇 |
神经病学 | 41篇 |
特种医学 | 321篇 |
外科学 | 102篇 |
综合类 | 29篇 |
预防医学 | 47篇 |
眼科学 | 14篇 |
药学 | 139篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 75篇 |
出版年
2023年 | 5篇 |
2022年 | 3篇 |
2021年 | 8篇 |
2020年 | 18篇 |
2019年 | 24篇 |
2018年 | 35篇 |
2017年 | 31篇 |
2016年 | 31篇 |
2015年 | 49篇 |
2014年 | 37篇 |
2013年 | 59篇 |
2012年 | 35篇 |
2011年 | 41篇 |
2010年 | 58篇 |
2009年 | 59篇 |
2008年 | 39篇 |
2007年 | 119篇 |
2006年 | 33篇 |
2005年 | 45篇 |
2004年 | 22篇 |
2003年 | 22篇 |
2002年 | 28篇 |
2001年 | 29篇 |
2000年 | 22篇 |
1999年 | 21篇 |
1998年 | 80篇 |
1997年 | 80篇 |
1996年 | 71篇 |
1995年 | 62篇 |
1994年 | 44篇 |
1993年 | 51篇 |
1992年 | 8篇 |
1991年 | 16篇 |
1990年 | 13篇 |
1989年 | 50篇 |
1988年 | 33篇 |
1987年 | 34篇 |
1986年 | 27篇 |
1985年 | 23篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 27篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1977年 | 16篇 |
1976年 | 29篇 |
1975年 | 13篇 |
排序方式: 共有1620条查询结果,搜索用时 15 毫秒
11.
Effect of radial shock wave therapy for carpal tunnel syndrome: A prospective randomized,double‐blind,placebo‐controlled trial 下载免费PDF全文
Yung‐Tsan Wu Ming‐Jen Ke Yu‐Ching Chou Chih‐Ya Chang Ching‐Yueh Lin Tsung‐Ying Li Feng‐Mei Shih Liang‐Cheng Chen 《Journal of orthopaedic research》2016,34(6):977-984
Three recent studies demonstrated the positive effect of extracorporeal shock wave therapy (ESWT) for treating carpal tunnel syndrome (CTS). However, none have entirely proved the effects of ESWT on CTS because all studies had a small sample size and lacked a placebo‐controlled design. Moreover, radial ESWT (rESWT) has not been used to treat CTS. We conducted a prospective randomized, controlled, double‐blinded study to assess the effect of rESWT for treating CTS. Thirty‐four enrolled patients (40 wrists) were randomized into intervention and control groups (20 wrists in each). Participants in the intervention group underwent three sessions of rESWT with nightly splinting, whereas those in the control group underwent sham rESWT with nightly splinting. The primary outcome was visual analog scale (VAS), whereas the secondary outcomes included the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), cross‐sectional area (CSA) of the median nerve, sensory nerve conduction velocity of the median nerve, and finger pinch strength. Evaluations were performed before treatment and at 1, 4, 8, and 12 weeks after the third rESWT session. A significantly greater improvement in the VAS, BCTQ scores, and CSA of the median nerve was noted in the intervention group throughout the study as compared to the control group (except for BCTQ severity at week 12 and CSA at weeks 1 and 4) (p < 0.05). This is the first study to assess rESWT in a randomized placebo‐controlled trial and demonstrate that rESWT is a safe and effective method for relieving pain and disability in patients with CTS. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:977–984, 2016. 相似文献
12.
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation 总被引:7,自引:0,他引:7
Schwartz DL Ford EC Rajendran J Yueh B Coltrera MD Virgin J Anzai Y Haynor D Lewellen B Mattes D Kinahan P Meyer J Phillips M Leblanc M Krohn K Eary J Laramore GE 《Head & neck》2005,27(6):478-487
BACKGROUND: 2-deoxy-2[(18)F]fluoro-D-glucose-positron emission tomography (FDG-PET) imaging can be registered with CT images and can potentially improve neck staging sensitivity and specificity in patients with head and neck squamous cell cancer. The intent of this study was to examine the use of registered FDG-PET/CT imaging to guide head and neck intensity modulated radiotherapy (IMRT) planning. METHODS: Twenty patients with squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx underwent FDG-PET and contrast-enhanced CT imaging of the head and neck before neck dissection surgery. Combined FDG-PET/CT images were created by use of a nonrigid image registration algorithm. All IMRT plans were theoretical and were not used for treatment. We prescribed 66 Gy in 30 fractions to FDG-avid CT abnormalities and nodal zones directly involved with disease, without prophylactic coverage of uninvolved neck levels. Matched CT-guided IMRT plans designed according to the specifications of Radiation Therapy Oncology Group (RTOG) H-0022 were available for comparison. We investigated the feasibility of FDG-PET/CT-directed IMRT dose escalation in five patients with FDG-avid disease located away from critical normal structures. After 66 Gy, FDG-avid disease with 0.5-cm margins was boosted in 220 cGy increments until dose-limiting criteria were reached. RESULTS: Elimination of prophylactic coverage to FDG-PET/CT-negative neck levels markedly reduced mean dose (Dmean) to the contralateral parotid gland (p < .001) and Dmean to the laryngeal cartilage (p = .001). No FDG-PET/CT-directed plan missed pathologically verified nodal disease. During the dose escalation exercise, we successfully increased the dose to 95% of the planning target volume (PTV95%) to a mean of 7490 cGy (range, 7153-8098 cGy). CONCLUSIONS: We demonstrate early proof of the principle that FDG-PET/CT-guided IMRT planning can selectively target and intensify treatment of head and neck disease while reducing critical normal tissue doses. Routine clinical use of such planning should not be engaged until the accuracy of FDG-PET/CT is fully validated. Future directions, including refinement of treatment to gross disease and radiologically uninvolved neck nodal levels, are discussed. 相似文献
13.
Immunohistochemical localization of membrane and alpha-granule proteins in human megakaryocytes: application to plastic-embedded bone marrow biopsy specimens 总被引:12,自引:2,他引:12
Using a new technique for antigen localization, we have demonstrated platelet proteins in megakaryocytes in plastic-embedded biopsy specimens of normal human bone marrow. In a series of 25 specimens, megakaryocytes showed labeling with antibodies to the integral membrane glycoproteins IIIa, IIb, and the IIb-IIIa complex; granule membrane protein 140; and five alpha-granule matrix proteins: thrombospondin, factor VIII-related antigen, beta-thromboglobulin, platelet factor 4, and fibrinogen. The antibodies to the membrane glycoproteins IIIa, IIb, and IIb-IIIa produced diffuse cytoplasmic staining and heavier staining on the plasma membrane, whereas the antibodies to the alpha-granule matrix proteins produced a distinct granular staining within the cytoplasm. Staining for granule membrane protein 140 was also granular in distribution. Rare mononuclear cells consistent with megakaryocyte precursors were labeled with these markers. Other enzyme histochemical and lectin-binding studies showed that the enzyme alpha-naphthyl acetate esterase, the lectin Ulex europaeus I, and the periodic-acid Schiff reaction were consistent, but not specific, markers of megakaryocytes. This immunohistochemical technique should facilitate the examination of qualitative and quantitative changes in megakaryocytes in a variety of physiologic and pathologic processes. 相似文献
14.
Schwartz DL Rajendran J Yueh B Coltrera M Anzai Y Krohn K Eary J 《Archives of otolaryngology--head & neck surgery》2003,129(11):1173-1178
BACKGROUND: Accurate baseline staging is necessary to appropriately treat head and neck squamous cell carcinoma. [F-18]-fluorodeoxyglucose positron emission tomography (FDG-PET) is valuable for locoregional staging of primary head and neck disease. The effectiveness of FDG-PET for the detection of distant metastatic or synchronous disease remains unproven. OBJECTIVE: To investigate the utility of FDG-PET extended into the abdomen (extended-field FDG-PET) for wide-field staging of head and neck tumors. METHODS: This is a prospective institutional study of 35 consecutive patients diagnosed with American Joint Committee on Cancer (AJCC)-defined stage II-IV squamous cell carcinoma of the oral cavity, oropharynx, or larynx between September 2000 and June 2002. Thirty-three patients (94%) were eligible for analysis. All patients were routinely staged with chest radiography, liver function tests, and extended-field FDG-PET. Chest or abdominal computed tomographic scans were used as corroborative studies and were obtained only when one of the above tests indicated distant disease. RESULTS: Of 33 patients, 7 (21%) had evidence of distant disease by extend-field FDG-PET-4 with metastases and 3 with synchronous primary cancers of the aerodigestive tract. [F-18]-fluorodeoxyglucose PET detected hepatic, bone, gastrointestinal, and mediastinal disease not identified by chest radiography or liver function tests. Two of the 7 patients with FDG-avid distant disease had false-negative staging by all other tests, including computed tomography. CONCLUSIONS: Extended-field FDG-PET is feasible and may improve staging of primary head and neck squamous cell carcinoma. Use of staging FDG-PET must be explicitly described in reports from centers engaged in prospective research to facilitate comparison with historical results. 相似文献
15.
16.
Interactions between tazarotene and ultraviolet light 总被引:2,自引:0,他引:2
Hecker D Worsley J Yueh G Kuroda K Lebwohl M 《Journal of the American Academy of Dermatology》1999,41(6):927-930
Tazarotene in combination with phototherapy is being used clinically for the treatment of plaque psoriasis. This study investigates the dose of UVB light required to induce minimal erythema and the dose of UVA light required to induce immediate pigment darkening, with and without pretreatment with tazarotene 0.1% gel. The photostability of tazarotene is also assessed. Pretreatment with tazarotene 0.1% gel 3 times per week for 2 weeks before phototherapy significantly reduced the mean minimal erythema dose (MED) for UVB from 56.25 to 42.50 mJ/cm(2) (P <.01), and significantly reduced the mean UVA exposure required to induce immediate pigment darkening from 20.18 to 18.50 J/cm(2) (P <.05). A thin application of tazarotene gel immediately before phototherapy had no significant effect on the mean MED for UVB, whereas a thick application of the gel increased the MED slightly, from 56.25 to 62.50 mJ/cm(2) (P =.1). Tazarotene remained chemically stable when used in conjunction with UVB or UVA phototherapy. To reduce the patient's potential to burn or tan, we recommend initiating UVB phototherapy at 50% to 75% of the MED when it is used in combination with tazarotene. We also recommend initiating PUVA therapy at slightly lower doses than usual. Lower total doses of UVA or UVB may be needed when patients with psoriasis are treated concomitantly with tazarotene. 相似文献
17.
Cynthia Tsien Huey Tan Sowmya Sharma Naaventhan Palaniyappan Pramudi Wijayasiri Kristel Leung Jatinder Hayre Elizabeth Mowlem Rachel Kang Peter J Eddowes Emilie Wilkes Suresh V Venkatachalapathy Indra N Guha Lilia Antonova Angela C Cheung William JH Griffiths Andrew J Butler Stephen D Ryder Martin W James Guruprasad P Aithal Aloysious D Aravinthan 《Clinical medicine (London, England)》2021,21(1):e32
18.
Teachey DT Seif AE Brown VI Bruno M Bunte RM Chang YJ Choi JK Fish JD Hall J Reid GS Ryan T Sheen C Zweidler-McKay P Grupp SA 《Blood》2008,111(2):705-714
Patients with autoimmune lymphoproliferative syndrome (ALPS) and systemic lupus erythematosis (SLE) have T-cell dysregulation and produce abnormal, activated T lymphocytes and an atypical peripheral T-cell population, termed double negative T cells (DNTs). T-cell functions, including DNT transition in T-cell development and T-cell activation, are critically dependent on Notch signaling. We hypothesized that inhibiting Notch signaling would be effective in ALPS and SLE by reducing the production of abnormal DNTs and by blocking aberrant T-cell activation. We tested this hypothesis using murine models of ALPS and SLE. Mice were randomized to treatment with the notch pathway inhibitor (gamma-secretase inhibitor), N-S-phenyl-glycine-t-butyl ester (DAPT), or vehicle control. Response to treatment was assessed by measurement of DNTs in blood and lymphoid tissue, by monitoring lymph node and spleen size with ultrasound, by quantifying cytokines by bead-array, by ELISA for total IgG and anti-double-stranded DNA (dsDNA) specific antibodies, and by histopathologic assessment for nephritis. We found a profound and statistically significant decrease in all disease parameters, comparing DAPT-treated mice to controls. Using a novel dosing schema, we avoided the reported toxicities of gamma-secretase inhibitors. Inhibiting the Notch signaling pathway may thus present an effective, novel, and well-tolerated treatment for autoimmune and lymphoproliferative diseases. 相似文献
19.
20.